Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check57 days agoChange DetectedThe study has reduced its locations from 64 to 60, with specific locations in Brisbane, Queensland, and several international sites being removed. Additionally, new dates have been added for the study.SummaryDifference3%
- Check64 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study evaluating a gene therapy for hemophilia B, while a new registry identifier and version revision have been added.SummaryDifference12%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.